Using chromatin immunoprecipitation to monitor 1α,25-dihydroxyvitamin D3-dependent chromatin activity on the human CYP24 promoter

被引:16
|
作者
Väisänen, S [1 ]
Dunlop, TW [1 ]
Frank, C [1 ]
Carlberg, C [1 ]
机构
[1] Univ Kuopio, Dept Biochem, FIN-70211 Kuopio, Finland
来源
关键词
chromatin immunoprecipitation; CYP24; VDR; VDRE;
D O I
10.1016/j.jsbmb.2004.03.075
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We applied the chromatin immunoprecipitation (ChIP) method for the analysis of 1alpha,25-dihydroxyvitamin D-3 (1,25-D-3)-dependent chromatin activity on the human 24-hydroxylase (CYP24) promoter in MCF-7 human breast cancer cells. In this pilot study we concentrated on the proximal promoter (+22 to -424) of the CYP24 gene, which includes the known 1,25-D-3 response element (VDRE) cluster. A constitutively active region of the human histone 4a gene (-40 to +285) served for normalization. Chromatin activity snapshots were taken 0, 30, 60, 120, 180, 240 and 300 min after the onset of stimulation with 1,25-D-3 and anti-acetylated histone 4 antibodies were used for ChIP. Our results suggest that ChIP is suitable for monitoring 1,25-D-3-dependent changes of chromatin organization and can be used to reveal information about chromatin activity in living cells. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:277 / 279
页数:3
相关论文
共 50 条
  • [41] Cytoprotective action of 1α, 25-dihydroxyvitamin D3 in human melanocytes
    Sauer, B
    Ruwisch, L
    Kleuser, B
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2003, 367 : R15 - R15
  • [42] Altered pharmacokinetics of 1α,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse
    Masuda, S
    Byford, V
    Arabian, A
    Sakai, Y
    Demay, MB
    St-Arnaud, R
    Jones, G
    ENDOCRINOLOGY, 2005, 146 (02) : 825 - 834
  • [43] A Downstream Intergenic Cluster of Regulatory Enhancers Contributes to the Induction of CYP24A1 Expression by 1α,25-Dihydroxyvitamin D3
    Meyer, Mark B.
    Goetsch, Paul D.
    Pike, J. Wesley
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (20) : 15599 - 15610
  • [44] SYNTHESIS OF 24,24-DIHOMO-1-ALPHA,25-DIHYDROXYVITAMIN D-3
    TACHIBANA, Y
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1994, 42 (11) : 2349 - 2351
  • [45] A local effect of CYP24 inhibition on lung tumor xenograft exposure to 1,25-dihydroxyvitamin D3 is revealed using a novel LC-MS/MS assay
    Beumer, Jan H.
    Parise, Robert A.
    Kanterewicz, Beatriz
    Petkovich, Martin
    D'Argenio, David Z.
    Hershberger, Pamela A.
    STEROIDS, 2012, 77 (05) : 477 - 483
  • [46] Calcium-independent and 1,25-dihydroxyvitamin D3-dependent regulation of the renin-angiotension system in 25(OH)D1α-hydroxylase knockout mice
    Zhou, C.
    Lu, F.
    Goltzman, D.
    Miao, D.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S399 - S399
  • [47] Regulation of the expression of CYP24A1 (25-hydroxyvitamin D-24-hydroxylase) on the transcriptional level by UVB-induced synthesis of 1α, 25-dihydroxyvitamin D3 (calcitriol) in human keratinocytes
    Lehmann, B.
    Domaschke, D.
    Baer, M.
    Meurer, M.
    EXPERIMENTAL DERMATOLOGY, 2007, 16 (03) : 244 - 245
  • [48] 1β,25-Dihydroxyvitamin D3: A new vitamin D metabolite in human serum
    Pauwels, Steven
    Jans, Ivo
    Billen, Jaak
    Heijboer, Annemieke
    Verstuyf, Annemieke
    Carmeliet, Geert
    Mathieu, Chantal
    Maestro, Miguel
    Waelkens, Etienne
    Evenepoel, Pieter
    Bouillon, Roger
    Vanderschueren, Dirk
    Vermeersch, Pieter
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2017, 173 : 341 - 348
  • [49] Regulation of intestinal CYP3A by a 1α,25-dihydroxyvitamin D3-signaling pathway in rats
    Xu, Y
    Quigley, S
    Iwanaga, K
    Farin, F
    Thummel, K
    DRUG METABOLISM REVIEWS, 2003, 35 : 120 - 120
  • [50] Selective induction of intestinal CYP3A23 by 1α,25-dihydroxyvitamin D3 in rats
    Xu, Yang
    Iwanaga, Kazunori
    Zhou, Changcheng
    Cheesman, Matthew J.
    Farin, Federico
    Thummel, Kenneth E.
    BIOCHEMICAL PHARMACOLOGY, 2006, 72 (03) : 385 - 392